InsidersTradesSigma
Swedish Orphan Biovitrum AB (publ) Stock: price and insider trades · Finland · FIN-FSA
Track the Swedish Orphan Biovitrum AB (publ) stock price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are listed on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, Swedish Orphan Biovitrum AB (publ) has recorded 31 public disclosures. Market capitalisation: €166.3bn. The latest transaction was disclosed on 16 June 2026 (Sale). Among the most active insiders: Sofiane FAHMY. The full history is openly available.
31
Insider Decl.
0
Thresholds
€7m
24 ops.
Buy Volume
€7m
7 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Swedish Orphan Biovitrum AB (publ) Buy (bullish), based on 12 analysts. Average price target: SEK 481.25.
36Σ signal
Fundamental score
Ranked 14,644 of 25,921 companies
48.3
score / 100
Value40
Quality56
FCF yld3.3%
Earn yld0.3%
EV/EBITDA16.3x
ROE2.3%
Gross mgn78%
Net mgn1.7%
Debt/EBITDA1.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 16 June 2026
Declarations31 total
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
11,552 shares@ SEK 430.96440.0003% mcap87.2% of flowAktieFI:csv-2a8e2d36d4a5943b66e0
27,262 shares0AktieFI:csv-3c175778aea868597b4f
Ideal exit: 9 Mar 2027 (T+270)
15,032 shares0AktieFI:csv-9e5b4f47669d7b30b346
Ideal exit: 9 Mar 2027 (T+270)
16,779 shares0AktieFI:csv-507302ebcc50954bac22
Ideal exit: 9 Mar 2027 (T+270)
17,317 shares0AktieFI:csv-d9987ede2eb76c8cf531
Ideal exit: 9 Mar 2027 (T+270)
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
7,159 shares@ SEK 430.96440.0002% mcap17.8% of flowAktieFI:csv-084ead171c173a77aec4
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
9,529 shares@ SEK 430.96440.0002% mcap50.0% of flowAktieFI:csv-6e8a8ff5a99211138bbd
19,034 shares0AktieFI:csv-592b9d6bf16ee1b0c6f8
Ideal exit: 9 Mar 2027 (T+270)
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
9,529 shares@ SEK 430.96440.0002% mcap100.0% of flowAktieFI:csv-cbe6e0d41ec94d43a785
15,367 shares0AktieFI:csv-79645e1e7edd98e5f6dc
Ideal exit: 9 Mar 2027 (T+270)
15,422 shares0AktieFI:csv-b048247e5ebe99a3359b
Ideal exit: 9 Mar 2027 (T+270)
78,086 shares0AktieFI:csv-3d385d11b2e1e4183964
Ideal exit: 9 Mar 2027 (T+270)
8,039 shares0AktieFI:csv-ca4117a45ada9a415e09
Ideal exit: 9 Mar 2027 (T+270)
10,050 shares0AktieFI:csv-b80cf3425114dbc152c1
Ideal exit: 9 Mar 2027 (T+270)
13,640 shares0AktieFI:csv-162ed4c6cde8496deb0f
Ideal exit: 9 Mar 2027 (T+270)
62,329 shares@ SEK 444.430.0016% mcap29.4% of flowAktieFI:csv-1a5c13fb1f639dd6bf5a
62,329 shares@ SEK 208.110.0008% mcap13.8% of flowAktieFI:csv-12d101b1679fd7e7429e
Ideal exit: 5 Feb 2027 (T+270)
62,329 shares@ €19.15070.0008% mcap100.0% of flowAktieFI:A003Y500-2
Ideal exit: 5 Feb 2027 (T+270)
62,329 shares@ SEK 444.430.0016% mcap29.4% of flowAktieFI:csv-996b6f6b3457c1b19929
62,329 shares@ SEK 208.110.0008% mcap13.7% of flowAktieFI:csv-c55efdf57c116a137ad5
Ideal exit: 1 Feb 2027 (T+270)
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
68,104 shares@ €19.0920.0009% mcap100.0% of flowAktieFI:A003T085-1
Ideal exit: 21 Jul 2026 (T+270)
65,835 shares@ €19.0920.0008% mcap100.0% of flowAktieFI:A003T071-1
Ideal exit: 21 Jul 2026 (T+270)
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
3,588 shares@ €18.60230.0000% mcap100.0% of flowAktieFI:A003R197-1
Ideal exit: 27 Apr 2026 (T+270)
25 of 31 declarations
About Swedish Orphan Biovitrum AB (publ)
Swedish Orphan Biovitrum AB (publ) is a Swedish pharmaceutical company focused on developing treatments for rare diseases. It is listed on the Stockholm Stock Exchange under the symbol XSTO.